I agree that this site is using cookies. You can find further informations here.
X
Oluwole, Olalekan
249  results:
Search for persons X
?
1

Outpatient CAR T-Cell Therapy as Standard of Care: Current ..:

Gatwood, Katie ; Mahmoudjafari, Zahra ; Baer, Brittney...
Clinical Hematology International.  6 (2024)  2 - p. , 2024
Link: https://doi.org/10.46989..
 
?
2

Bridging therapy with axicabtagene ciloleucel for large B-c..:

Jain, Michael D. ; Jacobs, Miriam T. ; Gao, Feng...
Blood Advances.  8 (2024)  4 - p. 1042-1050 , 2024
Link: https://doi.org/10.1182/..
 
?
3

The Evolving Role of Bridging Therapy during CAR-T Therapy:

Bhaskar, Shakthi T ; Dholaria, Bhagirathbhai ; Savani, Bipin N.
Clinical Hematology International.  6 (2024)  3 - p. , 2024
Link: https://doi.org/10.46989..
 
?
4

Managing Infection Complications in the Setting of Chimeric..:

Ahmed, Nausheen ; Oluwole, Olalekan ; Mahmoudjafari, Zahra..
Clinical Hematology International.  6 (2024)  2 - p. , 2024
Link: https://doi.org/10.46989..
 
?
5

The Implementation of Chimeric Antigen Receptor (CAR) T-cel..:

Knight E, Tristan ; Oluwole, Olalekan ; Kitko, Carrie
Clinical Hematology International.  6 (2024)  1 - p. , 2024
Link: https://doi.org/10.46989..
 
?
6

Relapsed or refractory large B‐cell lymphoma after chimeric..:

Del Toro‐Mijares, Raul ; Oluwole, Olalekan ; Jayani, Reena V....
British Journal of Haematology.  201 (2023)  1 - p. 15-24 , 2023
Link: https://doi.org/10.1111/..
 
?
7

ASTCT Clinical Practice Recommendations for Transplantation..:

Epperla, Narendranath ; Kumar, Ambuj ; Abutalib, Syed A....
Transplantation and Cellular Therapy.  29 (2023)  9 - p. 548-555 , 2023
Link: https://doi.org/10.1016/..
 
?
8

P1125: DURABLES RESPONSES ACHIEVED WITH ANTI-CD19 ALLOGENEI..:

Munoz, Javier ; Locke, Frederick ; Lekakis, Lazaros...
HemaSphere.  7 (2023)  S3 - p. e8808264 , 2023
Link: https://doi.org/10.1097/..
 
?
9

P1694: COST-EFFECTIVENESS OF AXICABTAGENE CILOLEUCEL VS. TI..:

Oluwole, Olalekan ; Ray, Markqayne ; Davies, Neil...
HemaSphere.  7 (2023)  S3 - p. e200756c , 2023
Link: https://doi.org/10.1097/..
 
?
10

New targets for CAR T therapy in hematologic malignancies:

Savani, Malvi ; Oluwole, Olalekan ; Dholaria, Bhagirathbhai
Best Practice & Research Clinical Haematology.  34 (2021)  3 - p. 101277 , 2021
Link: https://doi.org/10.1016/..
 
?
11

Taking a BiTE out of the CAR T space race:

Patel, Ameet ; Oluwole, Olalekan ; Savani, Bipin.
British Journal of Haematology.  195 (2021)  5 - p. 689-697 , 2021
Link: https://doi.org/10.1111/..
 
?
12

Overview of approved CAR‐T therapies, ongoing clinical tria..:

Sengsayadeth, Salyka ; Savani, Bipin N. ; Oluwole, Olalekan.
eJHaem.  3 (2021)  S1 - p. 6-10 , 2021
Link: https://doi.org/10.1002/..
 
?
13

CAR T cell therapy in solid tumors: A review of current cli..:

Patel, Urvi ; Abernathy, John ; Savani, Bipin N...
eJHaem.  3 (2021)  S1 - p. 24-31 , 2021
Link: https://doi.org/10.1002/..
 
?
14

High Sensitivity Troponin T and NT-proBNP in Patients Recei..:

Oluwole, Olalekan ; Moslehi, Javid J. ; Salem, Joe-Elie...
Clinical Hematology International.  3 (2021)  3 - p. 96 , 2021
Link: https://doi.org/10.2991/..
 
?
15

Commercial Chimeric Antigen Receptor (CAR) T Cells: Unfamil..:

Byrne, Michael T. ; Oluwole, Olalekan ; Allen, Duncan...
Biology of Blood and Marrow Transplantation.  25 (2019)  3 - p. S302 , 2019
Link: https://doi.org/10.1016/..
 
1-15